Systematic review of cost and cost-effectiveness of different TB-screening strategies. - Wikidata - wikimedia - TriplyDB

Systematic review of cost and cost-effectiveness of different TB-screening strategies.

Systematic review of cost and cost-effectiveness of different TB-screening strategies.

http://www.wikidata.org/entity/Q34036168

about

Soluble markers of the Toll-like receptor 4 pathway differentiate between active and latent tuberculosis and are associated with treatment responses Screening of healthcare workers for tuberculosis: development and validation of a new health economic model to inform practice The strategic framework of tuberculosis control and prevention in the elderly: a scoping review towards End TB targets Correlation between tuberculin skin test and IGRAs with risk factors for the spread of infection in close contacts with sputum smear positive in pulmonary tuberculosis.Revisiting annual screening for latent tuberculosis infection in healthcare workers: a cost-effectiveness analysis.Tuberculosis screening at the Sainte-Anne Hospital in Paris - results of first and second IGRA.The Effectiveness of Family-Based DOTS versus Professional-Family Mix DOTS in Treating Smears Positive Tuberculosis Gamma Interferon Assays Used in the Diagnosis of Tuberculosis.The feasibility of the interferon gamma release assay and predictors of discordance with the tuberculin skin test for the diagnosis of latent tuberculosis infection in a remote Aboriginal community.QuantiFERON-TB gold in-tube implementation for latent tuberculosis diagnosis in a public health clinic: a cost-effectiveness analysis.How methodologic differences affect results of economic analyses: a systematic review of interferon gamma release assays for the diagnosis of LTBI Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results.Cost-effectiveness analysis of community active case finding and household contact investigation for tuberculosis case detection in urban Africa.Cost Effectiveness of Preventive Treatment for Tuberculosis in Special High-Risk Populations.Recent developments in the epidemiology and management of tuberculosis - new solutions to old problems?Regular Sputum Check-Up for Early Diagnosis of Tuberculosis after Exposure in Healthcare Facilities.Cost analysis of tuberculin skin test and the QuantiFERON-TB Gold In-tube test for tuberculosis screening in a correctional setting in Dallas, Texas, USA.Predictive value of the tuberculin skin test among newly arriving immigrants.The effect of introducing IGRA to screen French healthcare workers for tuberculosis and potential conclusions for the work organisation An update on granulomatous diseases of the oral tissues.Integrated screening for tuberculosis and HIV in tuberculosis contact investigations: lessons learned in North Carolina.Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.Tuberculosis in healthcare workers - a narrative review from a German perspective The history and evolution of immigration medical screening for tuberculosis.Performance of QuantiFERON-TB Gold and tuberculin skin test relative to subjects' risk of exposure to tuberculosis.Tuberculin skin test versus interferon-gamma release assays for the diagnosis of tuberculosis infection.A Systematic Review of Studies Evaluating the Cost Utility of Screening High-Risk Populations for Latent Tuberculosis Infection.Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA.Diagnosis of Ocular Tuberculosis.Controversies in ocular tuberculosis.Update on Immunological Test (Quantiferon-TB Gold) Contribution in the Management of Tuberculosis-Related Ocular Inflammation.A Cost-benefit Analysis of a Proposed Immigrant Latent Tuberculosis Infection Screening Program for Cyprus.Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis.Latent tuberculosis infection detection and active tuberculosis prevention in patients receiving anti-TNF therapy: an Italian nationwide survey.Cost-effectiveness of alternative strategies for interferon-γ release assays and tuberculin skin test in tuberculous uveitis.IGRA-positive patients and interferon-gamma/interleukin-2 signatures: can the Fluorospot assay provide further information?Cumulative Faults with Serial Testing for Latent Tuberculosis in Low-Risk Populations.Cost-effectiveness of using Quantiferon Gold (QFT-G)® versus tuberculin skin test (TST) among U.S. and foreign born populations at a public health department clinic with a low prevalence of tuberculosis.Updating a tuberculosis surveillance program: considering all of the variables.Moving toward tuberculosis elimination: implementation of statewide targeted tuberculin testing in Tennessee.

P2860

Q28534690-349C84C4-07D9-4817-B38A-33F99B960BA0 Q28731558-ED7190CE-AE2A-4C2A-B76C-DCF219B922D6 Q30234304-CE8F36DE-37E4-4D38-B484-DB8220DD5188 Q30391651-F93445F6-CC90-4A17-9787-6CD658E9B119 Q33702764-84BFF54F-735B-4EAC-A319-3F96B71CFB4E Q33890563-5C004744-F5F8-427F-8470-710C2ACD8A5F Q34003342-56F9A9C2-972F-4746-91D4-B8122B9E99B5 Q34478200-95F08128-B6BD-4269-8C19-06F54320F43A Q34489446-A7D132C5-B054-41EE-88AD-636336511D47 Q34518338-80977D73-D1D3-4FC7-9FC2-CDE6895C5850 Q34625452-0F146BA8-E46E-4C36-8DA2-636788E994CE Q34670617-7935061C-5FDF-4973-A9BC-7D7466AD4663 Q35057710-882ACE54-0860-44CE-B072-CA87F69E66CD Q35577840-FC284017-8CEE-45B9-B4DC-427E8A0ED741 Q35715390-C02D3548-150D-4248-887E-9BC52E5E1805 Q36040016-D2C9AE92-9187-4573-B030-B8970CA76102 Q36161757-10D858DD-60F9-49A7-82CF-358093FEFFB0 Q36721145-F819A65D-CAC8-46F2-AB31-4CB6F9A44808 Q36836585-E414BB4B-D216-4186-A883-E3CA76649CA4 Q37177491-0D1FEE28-1D9B-4B6D-92BF-08D2E05BC5D9 Q37391637-CAD18215-8DB2-4B91-BF60-82E4E5D3E2A5 Q37544916-F79B4AA4-906B-479C-935C-B54694E99CC0 Q37699705-0E7AE5A3-0C9A-467A-8F6E-A36D39F20B2A Q38081493-17BE4419-5D50-48A3-B3EE-148C1E2AEBD2 Q38192554-FE67DC61-4DF3-44CA-9D74-ABB5D510F485 Q38228997-4C58EA36-BC2C-4884-8820-AE052D8218B4 Q38541022-57DDFFF7-AABC-451D-882D-5C0C3CB01918 Q38791152-3782BF85-5430-46CA-9906-5C9EDB917CC6 Q38886299-F0907E76-5DBE-4199-AD60-8656C3B56FF3 Q38999122-AE4306D1-E0FC-434D-A812-E0918F267181 Q39430616-4064E662-C644-4907-84D7-814546170FEA Q40351156-1A8193BB-1FC0-4149-9276-76F43F4EE674 Q40757959-4FBC2D8F-95A3-418E-933F-39499DE67F77 Q41109448-3E7E6D1D-41B6-4040-830D-E96C3C2CBC2F Q41554395-1F47D97D-E06B-4A9E-BEB6-BCB69D19424F Q42230560-1A2ABB94-3B93-4A16-813A-586350C24F21 Q43603731-F5CB97C0-AAB8-4936-AFA0-0530B1D5E25F Q43652113-A700D86F-FFC0-4FE4-B98E-01151BEC61C8 Q44977071-9B7BEE9D-6B90-41E3-ACA4-7F07563210C0 Q45988272-1F4E2EE3-7FE9-4D38-8069-93D7806583C6

P2860

Systematic review of cost and cost-effectiveness of different TB-screening strategies.

http://www.wikidata.org/entity/Q34036168

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Systematic review of cost and cost-effectiveness of different TB-screening strategies.

@ast

Systematic review of cost and cost-effectiveness of different TB-screening strategies.

@en

Systematic review of cost and cost-effectiveness of different TB-screening strategies.

@nl

type

label

Systematic review of cost and cost-effectiveness of different TB-screening strategies.

@ast

Systematic review of cost and cost-effectiveness of different TB-screening strategies.

@en

Systematic review of cost and cost-effectiveness of different TB-screening strategies.

@nl

prefLabel

Systematic review of cost and cost-effectiveness of different TB-screening strategies.

@ast

Systematic review of cost and cost-effectiveness of different TB-screening strategies.

@en

Systematic review of cost and cost-effectiveness of different TB-screening strategies.

@nl

P1433

Q34036168-695F77A5-49D4-47D2-8F58-8794C75C5AA1

P1476

Q34036168-4442CADD-0148-4E16-AC81-8117DA2A32FE

P2093

Q34036168-009A598F-DA42-442B-8F86-AE1FE1A10BEF

Q34036168-095717F3-F5B7-46ED-A334-167A7314CCA0

Q34036168-316F8860-5B11-486E-8F0E-45AA1504B0B1

Q34036168-59403934-7F85-479E-B27D-9BE48D3C2646

P275

Q34036168-DEF69963-11DA-4371-A526-01904FE7D26D

P2860

Q34036168-09666544-34A5-44AD-8C14-7399118A62B9

Q34036168-0DDD4157-7B87-4D68-8CE5-A4B49018BCE9

Q34036168-20CB10B5-09B5-4807-B792-99FAE4DE25BF

Q34036168-233FC5C6-FFF6-4922-88A9-411263EC5D60

Q34036168-49638B47-EE0B-43DE-8221-F90465C03C3C

Q34036168-4DA6519E-21F7-4395-8946-C2056701DEFE

Q34036168-50465FEE-BBD2-4B3A-B94D-87D52123FB65

Q34036168-562349BF-5C57-49D7-8C80-4B7524E4BB82

Q34036168-5D0013D3-4E48-4982-B8EF-28D7EC5C2BE0

Q34036168-5E5334F8-7612-435F-9EAC-5C07221F0461

P2888

Q34036168-154FCA62-74EB-4424-8981-CA534E30C9CF

P304

Q34036168-057B9473-D79D-4F95-8CCF-769996B70761

P31

Q34036168-81DF02F5-8769-4E3D-8A1A-335B24045EBA

Q34036168-A5B0C552-141E-458C-9CFA-34E44430A9DE

P356

Q34036168-BFA0789F-3671-4759-A20E-33C653674D38

P478

Q34036168-F8DCBEFD-FE19-439F-9194-3CB814527443

P5008

Q34036168-E0404FC4-0DB4-47A1-9FE1-98E39990CDE1

P577

Q34036168-85F38D1D-9965-46B9-A4E0-C91926F3B1EA

P5875

Q34036168-DF3A7D85-0556-4937-8218-8BC34E862014

P6179

Q34036168-A35AB4D5-B6CC-412B-973A-9D1497C63BCE

P698

Q34036168-EB3EDC2C-020C-4C64-BE6D-6CC604621359

P921

Q34036168-2B494569-0992-46E5-82B3-FDCB0CB01211

Q34036168-4CB7D99A-EDD9-4A35-8245-1266FEB12427

Q34036168-56D5110D-3B3D-4AA3-AA5B-3239C815EAD3

Q34036168-A3AC548C-52E2-4405-B169-C2DBB12AA57D

P932

Q34036168-9C3E5B74-214D-4F4D-9FEA-9709E368519B

P356

1472-6963-11-247

P1433

BMC Health Services Research

P1476

Systematic review of cost and cost-effectiveness of different TB-screening strategies.

@en

P2093

Albert Nienhaus

http://www.w3.org/2001/XMLSchema#string

Anja Schablon

http://www.w3.org/2001/XMLSchema#string

José Torres Costa

http://www.w3.org/2001/XMLSchema#string

Roland Diel

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis

Advances in the diagnosis and treatment of tuberculosis.

Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis

Specific immune-based diagnosis of tuberculosis.

What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us?

Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review.

Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States.

Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005.

Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis.

Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis.

P2888

1472-6963-11-247

P304

247

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1472-6963-11-247

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2011-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51684019

http://www.w3.org/2001/XMLSchema#string

P6179

1046384654

http://www.w3.org/2001/XMLSchema#string

P698

21961888

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary tuberculosis

preventive health services

immunologic tests

biomedical investigative technique

P932

3196701

http://www.w3.org/2001/XMLSchema#string